Arcturus Therapeutics Holdings

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.

About ARCT

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. 

CEO
Joseph E. Payne
CEOJoseph E. Payne
Employees
176
Employees176
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2013
Founded2013
Employees
176
Employees176

ARCT Key Statistics

Market cap
182.69M
Market cap182.69M
Price-Earnings ratio
-2.61
Price-Earnings ratio-2.61
Dividend yield
Dividend yield
Average volume
745.07K
Average volume745.07K
High today
$6.79
High today$6.79
Low today
$6.38
Low today$6.38
Open price
$6.56
Open price$6.56
Volume
520.49K
Volume520.49K
52 Week high
$24.17
52 Week high$24.17
52 Week low
$5.85
52 Week low$5.85

Stock Snapshot

Arcturus Therapeutics Holdings(ARCT) stock is priced at $6.42, giving the company a market capitalization of 182.69M. It carries a P/E multiple of -2.61.

During the trading session on 2025-12-19, Arcturus Therapeutics Holdings(ARCT) shares reached a daily high of $6.79 and a low of $6.38. At a current price of $6.42, the stock is +0.7% higher than the low and still -5.4% under the high.

Trading activity shows a volume of 520.49K, compared to an average daily volume of 745.07K.

The stock's 52-week range extends from a low of $5.85 to a high of $24.17.

The stock's 52-week range extends from a low of $5.85 to a high of $24.17.

ARCT News

TipRanks 4d
Arcturus Therapeutics Announces CFO Departure and Replacement

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...

Analyst ratings

73%

of 11 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

People also own

Based on the portfolios of people who own ARCT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.